Form 4: Precigen Director James Turley Acquires Shares

Precigen Director James S. Turley acquired 71,839 shares of common stock on March 13, 2026, through the vesting of restricted stock units.

Summary

• James S. Turley, a Director of Precigen, Inc. (PGEN), acquired 71,839 shares of common stock.
• The acquisition occurred on March 13, 2026, as a result of the full vesting of restricted stock units (RSUs).
• Each RSU represented a contingent right to receive one share of Precigen common stock, with a derivative security price of $0.
• Following this transaction, Mr. Turley beneficially owns 685,417 shares of Precigen common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine, pre-scheduled vesting of equity compensation for a director, which is neither overtly positive nor negative for the company's immediate prospects.

Positives

• The acquisition of shares by a director through RSU vesting indicates continued alignment of management interests with shareholder value.
• Increased direct ownership by a director can signal confidence in the company's future prospects.

Negatives

• No specific negative points are identified in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as the vesting of restricted stock units, are common occurrences in publicly traded companies. While not indicative of a new strategic direction, they reflect the ongoing compensation structure for directors and executives, aligning their long-term interests with company performance.

Comparison to Industry Standards

• This Form 4 filing details a standard RSU vesting event for a director, which is a common equity compensation practice across various industries, including biotechnology. There are no specific comparable companies or projects mentioned in the filing to assess against industry benchmarks.

Related Party Transactions

• The transaction itself is a related party transaction (director acquiring shares from the company) as part of an equity compensation plan.

Stakeholder Impact

• Shareholders: The transaction increases the director's direct ownership, potentially aligning interests.
• Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this filing.

Next Steps

• No specific future actions, events, or milestones are mentioned beyond the completion of this transaction.

Key Dates

Keywords

Precigen, PGEN, James S. Turley, Director, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Common Stock, Beneficial Ownership